BioSpace News Archive

MFG Chemical, a global leader in specialty and custom chemical manufacturing, has successfully renewed its ISO 9001:2015 Certifications at each of its three Dalton, Georgia facilities.

Halloran Consulting Group announced several key changes to its executive leadership team, including the promotions of Greg Dombal to President, Tania Zieja to Chief Financial Officer and Katie McCarthy to Chief Development Officer.

AIVITA Biomedical, Inc. announced that it will be presenting at the following investor, oncology and regenerative medicine conferences in October:

Merck (NYSE:MRK), known as MSD outside the United States and Canada, will hold its third-quarter 2019 sales and earnings conference call with institutional investors and analysts at 8:00 a.m. EDT on Tuesday, Oct. 29

CMP-001, a TLR9 Agonist, to be Evaluated in Combination with BAVENCIO®; with or without Utomilumab, a 4-1BB Agonist, and PF-04518600, an OX40 Agonist

Tmunity Therapeutics, Inc. announced it has entered into an exclusive license and research collaboration agreement with Children’s Hospital of Philadelphia to advance a glypican 2 chimeric antigen receptor T-cell therapy for the treatment of neuroblastoma, a rare cancer that affects the developing nervous system.

Avidity Biosciences announced the appointment of global business leader Sarah Boyce as President and Chief Executive Officer and a member of the Avidity Board of Directors.

Leading depression treatment provider aligns with NeuroStar® Advanced Therapy patients to share empowering personal stories and fight mental health stigma

Novocure (NASDAQ: NVCR) announced today that it will report financial results for the third quarter 2019 on Thursday, October 31, 2019, before the U.S. financial markets open

Chronometriq, the Montreal-based provider of access-to-care and patient engagement tools, announced that the company has secured more than $20 million CAD in Series B funding.